Cutler Group LP Axogen, Inc. Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 07, 2020	SELL	$8.38 - $17.34 $10,056 - $20,808	-1,200 Closed	0 $0
Q3 2019 Oct 28, 2019	SELL	$12.09 - $20.46 $153,543 - $259,842	-12,700 Reduced 91.37%	1,200 $1,000
Q3 2018 Nov 07, 2018	BUY	$34.05 - $55.9 $459,674 - $754,650	13,500 Added 3375.0%	13,900 $4,000
Q2 2018 Aug 10, 2018	SELL	$36.15 - $52.5 $46,995 - $68,250	-1,300 Reduced 76.47%	400 $6,000
Q1 2018 May 11, 2018	BUY	$24.4 - $40.25 $14,640 - $24,150	600 Added 54.55%	1,700 $20,000
Q4 2017 Jan 17, 2018	SELL	$18.5 - $28.6 $1,850 - $2,860	-100 Reduced 8.33%	1,100 $0
Q3 2017 Oct 17, 2017	BUY	$14.65 - $19.35 $17,580 - $23,220	1,200	1,200 $11,000

163

36.1M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $779M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.